Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Cartesian tees up Phase 3 mRNA CAR-T study in myasthenia gravis
6 months ago
R&D
BMS inks deal with AI Proteins; Terns’ early-stage leukemia data
6 months ago
News Briefing
Roivant says long-shot drug for a rare lung disease failed its Phase 2 study
6 months ago
R&D
After deal about-face and a spinout, Maze assembles $115M Series D
6 months ago
Financing
Startups
Takeda to pay $200M for rights to anemia drug from Keros
6 months ago
Deals
Pharma
Gilead makes another ADC move, inking up to $415M pact with Tubulis
6 months ago
Startups
Deals
Revolution sells $600M in shares on back of RAS inhibitor portfolio updates
6 months ago
Financing
R&D
Roche teams up with Chicago autoimmune biotech COUR Pharmaceuticals
6 months ago
Deals
Pharma
Janux soars on early prostate cancer data that could challenge Novartis' Pluvicto
6 months ago
R&D
FDA defends increased use of guidance in new report to Congress
6 months ago
FDA+
Sanofi earmarks €1B for new insulin production factory in Beijing
6 months ago
China
Manufacturing
J&J looks to expand Tremfya in two pediatric indications
6 months ago
Pharma
FDA+
Scott Gottlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this country’
6 months ago
People
FDA+
Biocon lands FDA approval for another Stelara biosimilar
6 months ago
Pharma
FDA+
Olema, Novartis ink another agreement, this time for a late-stage breast cancer trial
6 months ago
Deals
R&D
Novocure says electric field therapy extends life for pancreatic cancer patients by two months
6 months ago
R&D
Senti Bio’s Phase 1 CAR-NK data; Allink raises $42M
6 months ago
News Briefing
Agenus launches biologics manufacturing business to generate cash
6 months ago
Financing
Manufacturing
Novartis pays $1B upfront for PTC's Phase 2 Huntington's drug
6 months ago
Deals
Pharma
Merus drug shows ‘unexpected improvement’ in second-line head and neck cancer study
6 months ago
R&D
Apogee targets Dupixent head-to-head next year as it outlines broad pipeline plans
6 months ago
R&D
Applied Therapeutics' rare disease drug gets a CRL
6 months ago
R&D
FDA+
FDA is looking into hematology risks after patients take bluebird's Skysona gene therapy
6 months ago
Pharma
Cell/Gene Tx
Satsuma's NDA filing after CMC woes; Hovione's Irish and US expansion
6 months ago
Manufacturing
First page
Previous page
70
71
72
73
74
75
76
Next page
Last page